Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pulmonx (LUNG) Income from Continuing Operations (2019 - 2025)

Historic Income from Continuing Operations for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to -$14.0 million.

  • Pulmonx's Income from Continuing Operations rose 137.79% to -$14.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$56.7 million, marking a year-over-year increase of 71.22%. This contributed to the annual value of -$56.4 million for FY2024, which is 731.23% up from last year.
  • Per Pulmonx's latest filing, its Income from Continuing Operations stood at -$14.0 million for Q3 2025, which was up 137.79% from -$15.2 million recorded in Q2 2025.
  • Pulmonx's Income from Continuing Operations' 5-year high stood at -$10.2 million during Q3 2021, with a 5-year trough of -$16.2 million in Q2 2023.
  • Moreover, its 5-year median value for Income from Continuing Operations was -$14.2 million (2022), whereas its average is -$14.1 million.
  • Its Income from Continuing Operations has fluctuated over the past 5 years, first plummeted by 16375.65% in 2021, then soared by 1322.19% in 2024.
  • Quarter analysis of 5 years shows Pulmonx's Income from Continuing Operations stood at -$13.0 million in 2021, then dropped by 9.89% to -$14.3 million in 2022, then increased by 2.77% to -$13.9 million in 2023, then increased by 5.41% to -$13.1 million in 2024, then fell by 6.24% to -$14.0 million in 2025.
  • Its Income from Continuing Operations stands at -$14.0 million for Q3 2025, versus -$15.2 million for Q2 2025 and -$14.4 million for Q1 2025.